Gene edited endophytes
AgResearch and its partners have commenced a process toward seeking permission to operate a ‘contained’ outdoor growing trial of ryegrass with gene-edited additions, in what would be the first application of its type in New Zealand in well over a decade.
Written material was lodged recently to start the process, and it is expected that a full formal application may be made in the coming months to the Environmental Protection Authority (EPA) to grow ryegrass that contains gene-edited Epichloë endophytes at a suitable site in New Zealand. The continuation of the application process will be contingent on the outcomes of engagement with affected parties that is now underway.
These Epichloë endophytes live inside ryegrass and form a mutually beneficial relationship with the ryegrass. Natural substances released by the endophytes deter
insect pests from eating the ryegrass and improve plant growth and persistence,which collectively results in a reduced need for chemical pesticides and increases efficiencies in milk and meat production for New Zealand.
An estimated 90 per cent of proprietary ryegrass now sold in New Zealand contains a selected endophyte strain, while the economic impact in New Zealand of the AR37 version alone has been estimated at NZ$3.6 billion over 20 years.
The challenge has always been that some endophytes that protect ryegrass against pests also produce toxins that can be harmful to the livestock which feed on the ryegrass, causing heat stress or a disease called ryegrass staggers.
AgResearch scientists, supported by commercial partners PGG Wrightson Seeds and Grasslanz Technology, have identified in the lab targeted changes to the DNA of selected endophytes via gene editing that result in either greater plant protection or less harm to livestock.
The last approval of its type for an outdoor plant growing trial in New Zealand was by the then Environmental Risk Management Authority in December 2010, for research institute Scion to grow genetically modified Radiata pine trees.
The process is underway with ryegrass containing gene-edited endophytes, ahead of other edited or modified plant organisms, partly due to the very low risk of genetic material travelling outside of the trial site. A contained trial means that genetic material that can be reproduced is confined to that site. The edited endophytes are contained in the ryegrass seed and do not travel via the ryegrass pollen.
As part of the application process, AgResearch and its partners will be engaging with various interested and affected parties to understand and address any concerns that are raised.
If approved, the proposed trial would allow scientists to test how the ryegrass with gene-edited endophytes grow in outdoor conditions in New Zealand, as well as their
resistance to insect pests.
Meanwhile, outdoor trialling of ryegrass containing these gene-edited endophytes is underway in Australia and the ryegrass seed has recently been sown by partners at locations in both Victoria and New South Wales.
These Australian trials are each expected to run for a total of three years and measurements will be taken along the way on the plant persistence, yield, insect damage, chemistry and the level of endophyte presence in the ryegrass.